Cannabinoid signalling in TNF-alpha induced IL-8 release

Mormina, Maria E., Thakur, Shori, Molleman, Areles, Whelan, Cliff J. and Baydoun, Anwar R. (2006) Cannabinoid signalling in TNF-alpha induced IL-8 release. European Journal of Pharmacology, 540 (1-3). pp. 183-190. ISSN 0014-2999

Full text not available from this repository.

Abstract

The molecular events mediating the immunomodulatory properties of cannabinoids have remained largely unresolved. We have therefore investigated the molecular mechanism(s) through which R-(+)-[2,3-dihydro-5-methyl-3-[(morpholinyl)methyl] pyrrolo[1,2,3-de]-1,4-benzoxazinyl]-(1-napthanlenyl) methanone (WIN55212-2) modulate production of interleukin-8 (IL-8) in HT-29 cells. Release of IL-8 induced by tumor necrosis factor-alpha (TNF-alpha) was determined by enzyme-linked immunosorbent assay (ELISA). Changes in expression of inhibitory kappa B (IkappaB) were monitored by Western blotting and activation of nuclear factor-kappa B (NF-kappaB) was determined in electrophoretic mobility shift assay (EMSAs). TNF-alpha induced release of IL-8 was inhibited by WIN55212-2 which also blocked the degradation of IkappaB-alpha and activation of NF-kappaB induced by TNF-alpha. These data provide strong evidence that WIN55212-2 may modulate IL-8 release by negatively regulating the signaling cascade leading to the activation of NF-kappaB. These findings highlight a potential mechanism for the immunomodulatory properties of cannabinoids and contribute towards acquiring a clear understanding of the role of cannabinoids in inflammation.

Item Type:	Article
Faculty \ School:	Faculty of Science > School of Biological Sciences Faculty of Science > School of Chemistry
Depositing User:	Maru Mormina
Date Deposited:	22 Jun 2011 11:20
Last Modified:	24 Oct 2022 01:38
URI:	https://ueaeprints.uea.ac.uk/id/eprint/31816
DOI:	10.1016/j.ejphar.2006.04.015

Actions (login required)

View Item